Accelerating sales while ensuring compliance with GPP
Sharing digital content with physicians, while maintaining regulatory compliance, is getting easier with new technologies.
Sharing digital content with physicians, while maintaining regulatory compliance, is getting easier with new technologies.
As the industry faces ever more intense scrutiny of its marketing practices, pharma companies are challenged to comply with an increasingly complex web of regulations governing sales communication. Constantly evolving guidelines, regulations and laws make it increasingly difficult for life sciences companies to provide scientific, promotional and educational materials to healthcare practitioners. But since practitioners often view companies as a valuable source of information, pharma sales organizations need ways to facilitate that communication while ensuring compliance with Good Promotional Practices (GPP) such as the FDA's Good Reprint Guidance.
Maureen Shaffer of Prolifiq, a technology provider that helps sales professionals use digital content in their communications with customers and prospects in highly regulated environments, spoke with eyeforpharma recently about how messaging solutions can help pharma reps match approved content to their selling conversations, wrap it in branded messages and measure the effectiveness of their communications.
About the speaker
As vice president of Life Sciences for Prolifiq, Maureen Shaffer is responsible for strategic leadership and definition of products, services, and strategy for the pharmaceutical, medical device, and biotech space. She is focused on providing cloud-based software and solutions that systematically and comprehensively embed Good Promotional Practices into sales and marketing practices, allowing companies to comply with an increasingly complex web of regulations governing sales communication. Prolifiq for Life Sciences is used to organize, send and track approved sales materials with digital content to health care practitioners.
Maureen brings more than 20 years of experience marketing complex medical technologies working with industry-leading medical device companies. Most recently, she was Vice President of Marketing at InSet Technologies, Inc., a developer of implantable pumps for targeted intraspinal drug delivery to treat chronic pain. Prior to that, Maureen was Vice President of Marketing at AtriCure, Inc., a NASDAQ-listed pioneer in minimally invasive cardiac ablation. At both companies, she was a Prolifiq customer. Maureen's extensive career includes launching the first angioplasty balloon with Cordis Corporation; introducing a market-changing product to replace vascular sutures at United States Surgical; and bringing to market more than 100 minimally invasive cardiac surgery devices at Heartport, Inc. She holds a B.S. in biomedical engineering from Duke University.